1. Canadians warned of intravascular haemolysis risk with WinRh0 SDF

   News item 21 January 2013 Pages: 2 - 2

2. Reports of parotid gland enlargement with rosiglitazone

   News item 21 January 2013 Pages: 2 - 2

3. US Hydrea and Droxia labels updated: cutaneous vasculitis

   News item 21 January 2013 Pages: 2 - 2

4. Cisplatin: CV changes in testicular cancer?

   Clinical study 21 January 2013 Pages: 3 - 3

5. Deaths associated with Tamiflu reported in Japan

   News item 21 January 2013 Pages: 3 - 3

6. Health Canada warns against the use of Libidfit

   Media release 21 January 2013 Pages: 3 - 3

7. New Boxed Warning for Nimotop in the US

   News item 21 January 2013 Pages: 3 - 3

8. Stronger liver disorder warnings for Ketek label in the EU

   Media release 21 January 2013 Pages: 3 - 3

9. Children's laryngeal responses differ with anaesthetic agents

   Clinical study 21 January 2013 Pages: 4 - 4

10. Moxifloxacin and levofloxacin beat to the same cardiac rhythm

    Clinical study 21 January 2013 Pages: 4 - 4

11. Aprotinin use linked to renal, CV and cerebrovascular AEs

    Clinical study 21 January 2013 Pages: 5 - 5

12. CMF-related early menopause in cancer survivors

    Clinical study 21 January 2013 Pages: 5 - 5

13. Mifepristone: analysis of serious and life-threatening AEs

    News item 21 January 2013 Pages: 5 - 5

14. Use of drugs under pharmacogenetic influence common in primary care

    Clinical study 21 January 2013 Pages: 5 - 5

15. Alemtuzumab

    Case report 21 January 2013 Pages: 6 - 6

16. Aminolevulinic acid

    Case report 21 January 2013 Pages: 6 - 6

17. Antiretrovirals

    Case report 21 January 2013 Pages: 6 - 6

18. Atazanavir

    Case report 21 January 2013 Pages: 6 - 7

19. Atovaquone/proguanil

    Case report 21 January 2013 Pages: 7 - 7

20. Benzocaine overdose

    Case report 21 January 2013 Pages: 7 - 7

21. Bexarotene

    Case report 21 January 2013 Pages: 7 - 7

22. Bleomycin

    Case report 21 January 2013 Pages: 8 - 8

23. Botulinum toxin

    Case report 21 January 2013 Pages: 8 - 8

24. Botulinum toxin A

    Case report 21 January 2013 Pages: 8 - 8

25. Bupropion

    Case report 21 January 2013 Pages: 8 - 9

26. Capecitabine interaction

    Case report 21 January 2013 Pages: 9 - 9

27. Cefodizime

    Case report 21 January 2013 Pages: 9 - 9

28. Cefoperazone

    Case report 21 January 2013 Pages: 9 - 9

29. Cibenzoline

    Case report 21 January 2013 Pages: 9 - 10

30. Cidofovir

    Case report 21 January 2013 Pages: 10 - 10

31. Clozapine

    Case report 21 January 2013 Pages: 10 - 10

32. Clozapine

    Case report 21 January 2013 Pages: 10 - 10

33. Clozapine interaction

    Case report 21 January 2013 Pages: 10 - 10

34. Corticosteroids/fusidic acid/hydroxyquinoline sulfate

    Case report 21 January 2013 Pages: 11 - 11

35. Cyanoacrylate

    Case report 21 January 2013 Pages: 11 - 11

36. Cyclophosphamide/prednisolone

    Case report 21 January 2013 Pages: 11 - 11

37. Daclizumab/sirolimus/tacrolimus

    Case report 21 January 2013 Pages: 11 - 12

38. Dapsone/lidocaine/metoclopramide

    Case report 21 January 2013 Pages: 12 - 12

39. Dexamethasone

    Case report 21 January 2013 Pages: 12 - 12

40. Dimethyl sulfoxide

    Case report 21 January 2013 Pages: 12 - 13

41. Efalizumab

    Case report 21 January 2013 Pages: 13 - 13

42. Ergot alkaloids

    Case report 21 January 2013 Pages: 13 - 13

43. Ethosuximide

    Case report 21 January 2013 Pages: 13 - 14

44. Fluindione

    Case report 21 January 2013 Pages: 14 - 14

45. Fluorouracil/folinic acid/irinotecan

    Case report 21 January 2013 Pages: 14 - 14

46. Fluvastatin

    Case report 21 January 2013 Pages: 14 - 14

47. Growth hormones

    Case report 21 January 2013 Pages: 15 - 15

48. Haloperidol

    Case report 21 January 2013 Pages: 15 - 15

49. Herbal Medicines

    Case report 21 January 2013 Pages: 15 - 15

50. Hetastarch

    Case report 21 January 2013 Pages: 15 - 16